Merrion Pharmaceuticals, Inc. Cuts IPO Price Range to $6-$7 per ADS

October 30, 2007 |

1 min read

Oct 30 (Reuters) - Merrion Pharmaceuticals Plc sharply cut its estimated initial public offering price range to $6 to $7 per American Depositary Share or 4.21 euros and 4.91 euros per ordinary share.

IPO

MORE ON THIS TOPIC

Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration

Mergers & acquisitions

Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend

December 10, 2025

·

1 min read

·

Annalee Armstrong

Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation

Obesity

After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B

December 9, 2025

·

2 min read

·

Dan Samorodnitsky

Microscope icon. Molecule and communication background. Connected lines with dots.

China

With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned

December 9, 2025

·

3 min read

·

Annalee Armstrong

Aircrafts landing and taking off at airport by night - vector illustration

Venture capital

Lilly, Novo GLP-1 Pricing Plans Clear Runway For Future Competitors

December 3, 2025

·

2 min read

·

Annalee Armstrong